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Valorization  
The present thesis discusses the potential interaction between the 
gastrointestinal tract, the gut microbiota and the effect of dietary fiber intake in the 
context of metabolic health. Further, the future implications and the relevance of the 
present results will be put into a societal and economical context.  
 
The most recent world health organization (WHO) report indicates that obesity 
has tripled in the last forty decades with more than 1.9 billion adults being overweight and 
more than 650 million being obese in 2016. Obesity develops as a result of positive energy 
balance caused by increased food intake accompanied by declining physical activity, most 
commonly manifesting in gradient weight gain over years. Further, obesity is a strong risk 
factor in the onset of other metabolic diseases such as type II diabetes mellitus (T2DM), 
and is also associated with development of certain cancers, depression and cardiovascular 
diseases. Thus, despite being a preventable disease, the obesity pandemic and its 
comorbidities pose a massive challenge to healthcare systems worldwide. Moreover, due 
to rising childhood obesity, the challenges of the obesity pandemic will only foreseeable 
accelerate in the future. Current obesity treatment mainly focuses on the counseling of 
lifestyle adaptions such as caloric restriction and physical activity. These lifestyle adaptions 
can effectively lead to weight loss and reverse progression to T2DM, but adherence to 
lifestyle changes is challenging. The lack of implementing a healthy life style in the long 
term inevitably leads to treatment failure. Hence, there is an urgent need to advance 
current treatment strategies to tackle the obesity pandemic and obesity-related disorders.  
Most recently, much attention has been drawn to the role of the gastrointestinal 
(GI) tract and especially the gut microbiota in the etiology of obesity. Thus, industry, as 
well as academia have put much effort into the development and study of dietary 
components targeting the gut microbiota and specific “beneficial” microbial species in 
order to improve parameters of human metabolism. However, there are still huge gaps in 
our understanding of the complex interactions between dietary components, the 
physiological functions of the GI tract, the gut microbiota and its metabolites in the context 
of metabolic health. The studies conducted in this thesis have been partly funded by the 
Top Institute for Food and Nutrition, (TIFN), a public-private partnership on pre-
competitive research in food and nutrition combining resources and expertise from both 
food industry and academia. By using industrial and academic resources, this thesis aimed 
to elucidate some of these interactions by means of different methodological approaches.  
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Our findings indicate that long-term supplementation with a dietary fiber 
(Arabinoxylan-Oligossacharide, AXOS) that clearly stimulates Bifidobacteria does not 
translate into beneficial metabolic changes in a healthy, normoglycemic population. Yet, 
AXOS- stimulated growth of Bifidobacteria may help to improve stool consistency and thus 
may have potential applications in patients suffering from functional GI disorders. Further, 
the supplementation of AXOS led to a decreased microbial diversity, which is associated 
with several GI diseases. Yet, these findings need to be interpreted in a 
microbiological/ecological context, a perspective that seems to lack in many prebiotic 
interventional studies. Further, our results show that microbial diversity may also depend 
on the colonic transit time, thereby adding an important covariate which should be 
considered in future interventional studies targeting the gut microbiota. Further, the 
results from this thesis may suggest more careful interpretation of microbial diversity in 
the context of prebiotic intervention studies. Further large-scale cross-sectional studies 
including segmental colonic transit are needed to validate our findings. Nevertheless, the 
results from this thesis elucidate the complex interaction between GI transit, the gut 
microbiota and dietary fibers in the context of metabolic health and further research, 
especially in humans is required to identify underlying mechanisms and drivers.  
Many human and animal studies emphasize the beneficial potential for 
microbially produced short-chain fatty acids on the human metabolism. Yet, in order to 
efficiently target SCFA production, it is important to understand their metabolism and 
covariates thereof. This thesis gave important insights into the latter, emphasizing that the 
gastrointestinal transit time is linked to fecal SCFA concentrations, a parameter often used 
in prebiotic intervention studies to indicate fermentation. Further, we emphasize that 
rather than fecal SCFA, the measurement of plasma SCFA may be more meaningful in the 
context of metabolic processes, since only plasma SCFA concentrations associated with 
several important metabolic markers. These results provide interesting considerations for 
future studies targeting lifestyle interventions thereby increasing their effectiveness to 
prevent chronic metabolic diseases.  
In this thesis, we report results from a proof-of concept studie funded by a 
partnership between the Netherlands Organization of Scientific Research and the 
Carbohydrate Competence Center, a private- public organization aiming to “generate, 
develop and share high-value knowledge in the field of carbohydrates, to promote 
innovation worldwide and contribute to healthy and sustainable societies”. The study 
reported in this thesis gave import insights into the effectiveness of dietary fiber 
combinations with the approach of directly translating in vitro findings into an acute in 
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vivo human interventional study. We show that a dietary fiber mixture induces beneficial 
metabolic effects on energy expenditure and postprandial insulin tolerance after one day 
intake in lean men. These results should encourage further research, especially 
investigating long-term beneficial effect of dietary fiber mixtures specifically targeting 
increased distal acetate production as a nutritional strategy to improve or metabolic 
health. Also, these results may provide direct lead for food industry to develop products 
with specific (combinations of) dietary fiber(s) which are most effective in counteracting 
or preventing obesity and type 2 diabetes mellitus. 
The studies described in this thesis have been or will be published in scientific 
journals in the field of nutrition and microbiology and thus will be partly available for the 
public and scientific community. Industrial partners as well as academic partners have 
contributed to this project by funding and knowledge exchange during meetings and 
presentations. Thus, given the interesting implications of this thesis, the development of 
novel food products such as dietary fiber mixtures may provide an interesting strategy 
within the existing collaborations between academia and industrial partners and may 
provide leads for industrial product development. Ultimately, and from the public health 
perspective, novel recommendations regarding specific fibers and mixtures may be 
implemented in dietary guidelines to more efficiently prevent development of T2DM and 
to combat obesity.  
